Over

million new cases of cancer have been diagnosed (2020)

million deaths due to cancer (2020)

Over

Vietnamese people die from cancer every day

every

people, 1

person carries a cancer-causing gene (*)

Source: Global Cancer Statistics 2020

(*) Source: Data according to research by the Medical Genetics Institute—Gene Solutions

MAJOR ETIOLOGIES OF CANCER

The development of cancer in individuals results from the interaction of three factors:

– Genetics (genes)

– Lifestyle (diet, exercise, etc.)

– Environment (air and water quality, stress in life)

The oncoSure Plus genetic cancer screening test supports the analysis of cancer-related genetic components.
Learn more about the cancer detection, monitoring, and treatment tests offered by Gene Solutions
here

WHY SHOULD YOU TAKE THE ONCOSURE PLUS HEREDITARY CANCER SCREENING TEST?

ADVANTAGES OF ONCOSURE PLUS TEST

The results of the test allow for early detection of hereditary cancer risk:

Active cancer prevention includes medication treatment, and preventive surgery to reduce cancer risk.
Active screening helps early disease diagnosis, significantly improving cancer treatment outcomes.

Analyzing and determining the cause of hereditary cancer in the family.

Support consultations with geneticists and oncologists and free testing for three close relatives.

(*) Source: Statistics adapted from the American Cancer Society’s publication, Cancer Facts & Figures 2020, the ACS website, and the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program (all sources accessed January 2020)

PHẠM VI KHẢO SÁT

oncoSure Plus is a package of screening tests for 133 genes associated with 30 common hereditary cancers.

Including:

No	Genetic mutations associated with hereditary cancer	Testing genes
01	Skin Cancer	BAP1, BRAF, BRCA2, CBL, CDK4, CDKN2A, CYLD, DDB2, DKC1, ERCC2, ERCC3, ERCC4, ERCC5, FH, FLCN, HNF1A, KITLG, MAP2K1, MAP2K2, MITF, NRAS, POLH, PTCH1, PTEN, RECQL4, TINF2, TP53, WRN, XPA, XPC
02	Acute Leukemia (blood cancer)	ANKRD26, BUB1B, CBL, CEBPA, CEP57, EGFR, ELANE, ETV6, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, GATA2, NRAS, PAX5, PDGFRA, PRF1, PTPN11, RUNX1, SPRED1, SRP72, WT1
03	Colorectal Cancer	APC, AXIN2, BLM, BMPR1A, CBL, CDH1, CHEK2, DKC1, EPCAM, EXO1, GREM1, MLH1, MLH3, MSH2, MSH6, MUTYH, NRAS, NTHL1, PMS1, PMS2, POLD1, PTEN, SMAD4, SOS1, STK11, TP53


04	Breast Cancer	ATM, BARD1, BLM, BRCA1, BRCA2, CDH1, CHEK2, DKC1, MRE11A, NBN, NF1, PALB2, PMS1, PPM1D, PTEN, RAD50, SHOC2, SLX4, STK11, TP53, XRCC2
05	Lung Cancer	BRAF, DICER1, DKC1, EGFR, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, FLCN, KRAS, MAP2K1, MAP2K2, NRAS, RET, SMARCA4, SOS1, TERC, TERT
06	Kidney Cancer	BAP1, BUB1B, CDKN1C, CEP57, DICER1, DIS3L2, EPCAM, FH, HNF1A, MET, MLH1, MSH2, MSH6, PMS2, SDHB, VHL, WT1
07	Pancreatic Cancer	APC, BMPR1A, BRCA1, BRCA2, CDK4, CDKN2A, DKC1, EPCAM, MLH1, MSH2, MSH6, PALB2, PMS2, SMAD4, STK11, TP53
08	Ovarian Cancer	BRCA1, BRCA2, BRIP1, DICER1, EPCAM, ERCC1, MLH1, MRE11A, MSH2, MSH6, MUTYH, PALB2, PMS2, RAD51C, STK11, TP53
09	Stomach Cancer	APC, BMPR1A, CDH1, EPCAM, KIT, MLH1, MSH2, MSH6, NSUN2, PMS2, PTEN, SMAD4, STK11, TP53
10	Bladder Cancer	ATM, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, HRAS, RAF1
11	Endometrial Cancer	CBL, CDKN1C, EPCAM, FH, MLH1, MLH3, MSH2, MSH6, PMS2, PTEN, STK11, TP53
12	Prostate Cancer	BRCA1, BRCA2, EPCAM, EZH2, HOXB13, MLH1, MSH2, MSH6, PALB2, PMS2, TP53
13	Head and Neck Cancer	FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM
14	Brain Cancer	ERCC2, ERCC3, ERCC4, ERCC5, NF1, NSD1, PHOX2B, SUFU
15	Neural Paraganglioma	RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, VHL
16	Biliary Tract Cancer	BAP1, BRAF, KRAS, NRAS, TSC1, TSC2
17	Thyroid Cancer	CDKN1C, DICER1, RET, TINF2, WRN
18	Bone Cancer	EXT1, EXT2, RECQL4, SMARCB1
19	Multiple Endocrine Neoplasias	CDKN1B, MEN1, PRKAR1A, RET
20	Sarcoma	BUB1B, CEP57, HRAS
21	Liver Cancer	GPC3, HNF1A
22	Small Bowel Cancer	BMPR1A, KIT
23	Pituitary Tumor	AIP, DKC1
24	Neuroblastoma	ALK, HRAS
25	Nerve Fibroma	NF1, NF2
26	Adrenal Myeloma	MAX, RET, TMEM127
27	Parathyroid Cancer	CDC73
28	Retinoblastoma	RB1
29	Esophageal Cancer	RHBDF2
30	Multiple Myeloma	BRAF

The test is recommended by

American Society of Clinical Oncology

American Cancer Society

National Comprehensive Cancer Network

Ministry of Health

What do you get from the test package?

133 genes associated with 30 hereditary cancers are analyzed.

Detects mutations in family-inherited genes that increase the risk of common types of cancer. The test results help you evaluate the probability that you will have certain cancers for yourself and your family.

Guaranteed quality in every result.

Next-generation sequencing technology (Illumina) from the United States was developed by Vietnam’s leading medical advisors and a team of professionals. In only 14 days, a high-quality lab that complies with ISO standards will provide you with more than 99-percent-correct test results.

Genetic counseling from geneticists.

The team of experts and geneticists at Gene Solutions are always available to accompany you before and after each test and provide recommendations based on the results.

Simple to do and cost-effective

The USA standard DNA sampling kit, which allows you to collect samples at home in less than a minute, is painless and incredibly convenient.

Modify the treatment plan.

The results assist in tracking cancer/chronic disease progression and planning effective interventions. In addition, it is possible to improve the efficacy of treatment by choosing an appropriate regimen.

Free testing for family members.

If the initial test identifies a mutation, three family members will receive free testing. Take the initiative to prevent and protect your family’s health.

TESTING CANDIDATES

For hereditary cancer

PERSONAL HISTORY

You or a loved one* has a rare form of cancer (for example, ovarian cancer, pancreatic cancer, male breast cancer, metastatic prostate cancer, triple-negative breast cancer, medullary thyroid).
You or a loved one has been diagnosed with cancer earlier than usual (For example, colorectal cancer, endometrial cancer, or breast cancer diagnosed before age 50).
You or a loved one has numerous types of cancer simultaneously, and cancer may present in two different organs (for example, bilateral breast cancer or kidney cancer).
A colonoscopy revealed more than ten colorectal polyps.
Being of a race or ethnicity with a hereditary predisposition for cancer (Example: Ashkenazi Jew).

FAMILY HISTORY

First-degree relatives (parent, sibling, or child) with cancer of the same type (Example: mother, daughter, and sister with breast cancer, etc.).
Relatives on the same side (mother or father) have the same cancer or related cancers (for example, breast, ovarian, pancreatic, prostate or colorectal cancer, endometrial cancer, uterus, stomach, ovaries, pancreas).
A family member has a genetic mutation that increases the risk of cancer.

CONCERNED ABOUT THE POSSIBILITY OF HEREDITARY CANCER INHERITANCE

Relatives include siblings, children, father, mother, uncle, aunt, grandfather, and grandmother.

(*) Source: National Institutes of Health.

ONCOSURE PLUS TESTING PROCESS

Pre-test counseling

Blood collection and extracellular DNA separation

Extracellular DNA sequencing

Results return and post-test counseling

OTHER GENETIC PACKAGES

Analyzing 10 characteristics of personality, physique and genetic potential for children under 18.

Price: 2,500,000 ₫

Buy now

Call us

Analyzing 5 metabolic traits from adult genes.

Price: 2,500,000 ₫

Buy now

Call us

Analyzing 11 characteristics of personality, physique and potential for adults.

Price: 2,500,000 ₫

Buy now

Call us

Analyzing 5 skin health traits from adult genes.

Price: 2,500,000 ₫

Buy now

Call us

Screening for 133 genes, assessing the risk of 30 common inherited cancers.

Price: 10,000,000 ₫

Buy now

Call us

Q&A

The detection of cancer genes means proactive disease prevention and early detection. If a person is found to have a cancer-causing gene mutation, that person is at risk of developing cancer. A person who carries a disease-causing mutation is considerably more likely to get the disease than an ordinary individual who does not have the mutation. Knowing this risk beforehand allows patients to maximize routine cancer screening to detect cancer cells early and take proactive preventative steps to minimize the probability of disease development.

MAJOR ETIOLOGIES OF CANCER

WHY SHOULD YOU TAKE THE ONCOSURE PLUS HEREDITARY CANCER SCREENING TEST?

PHẠM VI KHẢO SÁT

The test is recommended by

What do you get from the test package?

133 genes associated with 30 hereditary cancers are analyzed.

Guaranteed quality in every result.

Genetic counseling from geneticists.

Simple to do and cost-effective

Modify the treatment plan.

Free testing for family members.

TESTING CANDIDATES

For hereditary cancer

PERSONAL HISTORY

FAMILY HISTORY

CONCERNED ABOUT THE POSSIBILITY OF HEREDITARY CANCER INHERITANCE

ONCOSURE PLUS TESTING PROCESS

OTHER GENETIC PACKAGES

Q&A

What are you searching for?​

Our services

Our company​

Support

What are you searching for?

Our company